SMS SOS: a randomized controlled trial to reduce self-harm and suicide attempts using SMS text messaging.
Deliberate self-harm
Intentional self-harm
Prevention
Randomized controlled trial
Re-present
Reattempt
SMS
Short message service
Suicide
Text message
Journal
BMC psychiatry
ISSN: 1471-244X
Titre abrégé: BMC Psychiatry
Pays: England
ID NLM: 100968559
Informations de publication
Date de publication:
18 04 2019
18 04 2019
Historique:
received:
24
08
2018
accepted:
05
04
2019
entrez:
20
4
2019
pubmed:
20
4
2019
medline:
22
1
2020
Statut:
epublish
Résumé
Hospital-treated deliberate self-harm (DSH) is common, costly and has high repetition rates. Since brief contact interventions (BCIs) may reduce the risk of DSH repetition, we aim to evaluate whether a SMS (Short Message Service) text message Intervention plus Treatment As Usual (TAU) compared to TAU alone will reduce hospital DSH re-presentation rates in Western Sydney public hospitals in Australia. Our study is a 24-month randomized controlled trial (RCT). Adult patients who present with DSH to hospital emergency, psychiatric, and mental health triage and assessment departments will be randomly assigned to an Intervention condition plus TAU receiving nine SMS text messages at 1, 2, 3, 4, 5, 6, 8, 10 and 12-months post-discharge. Each message will contain telephone numbers for two mental health crises support tele-services. Primary outcomes will be the difference in the number of DSH re-presentations, and the time to first re-presentation, within 12-months of discharge. This study protocol describes the design and implementation of an RCT using SMS text messages, which aim to reduce hospital re-presentation rates for DSH. Positive study findings would support the translation of an SMS-aftercare protocol into mental health services at minimal expense. This trial has been registered with the Australian and New Zealand Clinical Trials Registry (Trial registration: ACTRN12617000607370 . Registered 28 April 2017) and has been approved by two Local Health Districts (LHDs). Western Sydney LHD Human Research Ethics Committee approved the study for Westmead Hospital and Blacktown Hospital (Protocol: HREC/16/WMEAD/336). Nepean Blue Mountains LHD Research Governance Office approved the study for Nepean Hospital (SSA/16/Nepean/170).
Sections du résumé
BACKGROUND
Hospital-treated deliberate self-harm (DSH) is common, costly and has high repetition rates. Since brief contact interventions (BCIs) may reduce the risk of DSH repetition, we aim to evaluate whether a SMS (Short Message Service) text message Intervention plus Treatment As Usual (TAU) compared to TAU alone will reduce hospital DSH re-presentation rates in Western Sydney public hospitals in Australia.
METHODS/DESIGN
Our study is a 24-month randomized controlled trial (RCT). Adult patients who present with DSH to hospital emergency, psychiatric, and mental health triage and assessment departments will be randomly assigned to an Intervention condition plus TAU receiving nine SMS text messages at 1, 2, 3, 4, 5, 6, 8, 10 and 12-months post-discharge. Each message will contain telephone numbers for two mental health crises support tele-services. Primary outcomes will be the difference in the number of DSH re-presentations, and the time to first re-presentation, within 12-months of discharge.
DISCUSSION
This study protocol describes the design and implementation of an RCT using SMS text messages, which aim to reduce hospital re-presentation rates for DSH. Positive study findings would support the translation of an SMS-aftercare protocol into mental health services at minimal expense.
TRIAL REGISTRATION AND ETHICS APPROVAL
This trial has been registered with the Australian and New Zealand Clinical Trials Registry (Trial registration: ACTRN12617000607370 . Registered 28 April 2017) and has been approved by two Local Health Districts (LHDs). Western Sydney LHD Human Research Ethics Committee approved the study for Westmead Hospital and Blacktown Hospital (Protocol: HREC/16/WMEAD/336). Nepean Blue Mountains LHD Research Governance Office approved the study for Nepean Hospital (SSA/16/Nepean/170).
Identifiants
pubmed: 30999952
doi: 10.1186/s12888-019-2104-9
pii: 10.1186/s12888-019-2104-9
pmc: PMC6471753
doi:
Banques de données
ANZCTR
['ACTRN12617000607370']
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
117Références
Eur Psychiatry. 2005 Mar;20(2):101-9
pubmed: 15797693
Br J Psychiatry. 2007 Dec;191:548-53
pubmed: 18055960
Stat Med. 1990 Jun;9(6):645-56
pubmed: 2218168
Aust N Z J Psychiatry. 2004 Jul;38(7):520-5
pubmed: 15255824
Br J Psychiatry. 2015 Mar;206(3):184-90
pubmed: 25733570
Crisis. 2010;31(2):109-12
pubmed: 20418217
Aust N Z J Psychiatry. 2016 Oct;50(10):939-1000
pubmed: 27650687
J Clin Psychiatry. 2006 Oct;67(10):1599-609
pubmed: 17107253
PLoS One. 2014 Feb 28;9(2):e89944
pubmed: 24587141
Med J Aust. 1997 Aug 4;167(3):142-6
pubmed: 9269269
BMC Psychiatry. 2016 Jul 19;16:251
pubmed: 27435094
BMC Psychiatry. 2014 Nov 18;14:294
pubmed: 25404215